Literature DB >> 34105056

Framed Messages to Increase Condom Use Frequency Among Individuals Taking Daily Antiretroviral Medication for Pre-exposure Prophylaxis.

Jacklyn D Foley1,2, Madison Firkey3, Alan Sheinfil3, Jeremy Ramos3, Sarah E Woolf-King3, Peter A Vanable3.   

Abstract

PrEP delivery and routine care provide a unique opportunity to promote sexually transmitted infection (STI) prevention by both increasing STI testing frequency and creating a space for affirmative and effective safer sex counseling. This study was a feasibility and acceptability pilot of an adapted framed message intervention to increase condom use frequency with PrEP. In the formative phase, two focus groups with PrEP users (N = 7) provided feedback on a provisional loss-framed message intervention and identified potential study barriers. In the pilot trial, the adapted loss-framed message intervention was compared to a gain-framed message intervention and enhanced skills condition in a sample of PrEP users (N = 29). In terms of intervention feasibility, 58% of approached PrEP users completed the eligibility screen; 79% of those eligible enrolled in the study and 66% of enrolled participants completed the three-month follow-up. In terms of intervention acceptability, participants found the informational messages, regardless of assignment, to be moderately interesting (M = 6.24, SD = 2.97) and useful (M = 7.07, SD = 3.00), and very easy to understand (M = 9.50, SD = 0.97) on Likert-type scales ranging from 1 to 10. In terms of intervention effects, there was a small effect of the gain-framed intervention (b = .58, SE = .93, CI = -1.33, 2.48, Cohen's d = .26) on HIV/STI risk transmission. There was a small-medium effect of both the loss- (b = 2.00, SE = .90, CI = .15, 3.85, Cohen's d = 1.46) and gain-framed (b = 2.24, SE = .93, CI = .34, 4.15, Cohen's d = 1.65) interventions on condom use motivation. Finally, there was a medium-large effect of both the loss- (b = .97, SE = 1.33, CI = -1.88, 3.82, Cohen's d = .54) and gain-framed intervention (b = 1.97, SE = 1.33, CI = -.88, 4.82, Cohen's d = .87) on condom use frequency. Further refinement and testing, in a larger -scale trial with higher ecological validity than this initial pilot intervention, is warranted.

Entities:  

Keywords:  Framed informational messages; HIV; Pre-exposure prophylaxis (PrEP); Sexually transmitted infection (STI)

Year:  2021        PMID: 34105056     DOI: 10.1007/s10508-021-02045-1

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  32 in total

1.  Effective communication of risks to young adults: using message framing and visual aids to increase condom use and STD screening.

Authors:  Rocio Garcia-Retamero; Edward T Cokely
Journal:  J Exp Psychol Appl       Date:  2011-09

Review 2.  Health message framing effects on attitudes, intentions, and behavior: a meta-analytic review.

Authors:  Kristel M Gallagher; John A Updegraff
Journal:  Ann Behav Med       Date:  2012-02

3.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

Review 4.  The role of dispositional factors in moderating message framing effects.

Authors:  Judith Covey
Journal:  Health Psychol       Date:  2012-08-27       Impact factor: 4.267

5.  Web-Delivered CBT Reduces Heavy Drinking in OEF-OIF Veterans in Primary Care With Symptomatic Substance Use and PTSD.

Authors:  Michelle C Acosta; Kyle Possemato; Stephen A Maisto; Lisa A Marsch; Kimberly Barrie; Larry Lantinga; Chunki Fong; Haiyi Xie; Michael Grabinski; Andrew Rosenblum
Journal:  Behav Ther       Date:  2016-09-20

6.  Reactance to Health Warnings Scale: Development and Validation.

Authors:  Marissa G Hall; Paschal Sheeran; Seth M Noar; Kurt M Ribisl; Laura E Bach; Noel T Brewer
Journal:  Ann Behav Med       Date:  2016-10

7.  How we design feasibility studies.

Authors:  Deborah J Bowen; Matthew Kreuter; Bonnie Spring; Ludmila Cofta-Woerpel; Laura Linnan; Diane Weiner; Suzanne Bakken; Cecilia Patrick Kaplan; Linda Squiers; Cecilia Fabrizio; Maria Fernandez
Journal:  Am J Prev Med       Date:  2009-05       Impact factor: 5.043

8.  Brief Report: PrEP Uptake, Adherence, and Discontinuation Among California YMSM Using Geosocial Networking Applications.

Authors:  Ian W Holloway; Ryan Dougherty; Jennifer Gildner; Sean C Beougher; Craig Pulsipher; Jorge A Montoya; Aaron Plant; Arleen Leibowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.771

9.  An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database.

Authors:  Sophie A M Billingham; Amy L Whitehead; Steven A Julious
Journal:  BMC Med Res Methodol       Date:  2013-08-20       Impact factor: 4.615

10.  Member Checking: A Tool to Enhance Trustworthiness or Merely a Nod to Validation?

Authors:  Linda Birt; Suzanne Scott; Debbie Cavers; Christine Campbell; Fiona Walter
Journal:  Qual Health Res       Date:  2016-07-10
View more
  1 in total

1.  Awareness, Understanding and HIV Stigma in Response to Undetectable = Untransmittable Messages: Findings from a Nationally Representative Sample in the United Kingdom.

Authors:  Rory Coyne; Jane C Walsh; Chris Noone
Journal:  AIDS Behav       Date:  2022-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.